Understanding how sleep and circadian rhythms affect adolescent behavior and substance use risk
Data Management and Statistics Core
This study looks at how changes in sleep and body clocks during the teenage years can affect behaviors like substance use, with the goal of finding new ways to help teens stay healthy and avoid risky habits.
Quick facts
| Grant type | NIH-funded research |
|---|---|
| Study type | NIH-funded research |
| Funding institution | University of Pittsburgh at Pittsburgh NIH-funded |
| Lab location | 1 site (Pittsburgh, United States) |
| Project ID | NIH-10892091 on NIH RePORTER |
What this research studies
This research investigates how adolescent development influences sleep patterns and circadian rhythms, which in turn affect behaviors related to substance use. By manipulating sleep and circadian rhythms during adolescence, the study aims to determine their impact on reward responsiveness and cognitive control. The research involves managing and analyzing data from multiple projects to ensure high-quality and reproducible results. Patients may benefit from insights that could lead to new interventions aimed at reducing substance use risk among adolescents.
Who could benefit from this research
Good fit: Ideal candidates for participation are adolescents aged 12 to 20 who may be at risk for substance use due to behavioral or developmental factors.
Not a fit: Patients outside the age range of 12 to 20 or those not at risk for substance use may not benefit from this research.
Why it matters
Potential benefit: If successful, this research could lead to innovative strategies for preventing substance use and abuse in adolescents.
How similar studies have performed: Previous research has shown promising results in understanding the relationship between sleep patterns and adolescent behavior, suggesting that this approach could yield valuable insights.
Where this research is happening
Pittsburgh, United States
- University of Pittsburgh at Pittsburgh — Pittsburgh, United States (Active)
Researchers
- Principal investigator: Wallace, Meredith Joanne Lotz — University of Pittsburgh at Pittsburgh
- Study coordinator: Wallace, Meredith Joanne Lotz
About this research
- This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
- Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
- For full project details, budget, and progress reports, visit the official NIH RePORTER page below.